ITP
Iron Triangle Partners Portfolio holdings
AUM
$632M
This Quarter Return
+2.07%
1 Year Return
+26.53%
3 Year Return
+134.07%
5 Year Return
+312.1%
10 Year Return
–
AUM
$697M
AUM Growth
+$697M
(-28%)
Cap. Flow
-$292M
Cap. Flow
% of AUM
-41.91%
Top 10 Holdings %
Top 10 Hldgs %
63.57%
Holding
35
New
9
Increased
6
Reduced
11
Closed
9
Top Buys
| 1 |
Hologic
HOLX
|
$44.3M |
| 2 |
Envista
NVST
|
$23.8M |
| 3 |
HCA Healthcare
HCA
|
$23.6M |
| 4 |
Boston Scientific
BSX
|
$21.7M |
| 5 |
Acadia Healthcare
ACHC
|
$20.5M |
Top Sells
| 1 |
Waters Corp
WAT
|
$58.8M |
| 2 |
CTLT
CATALENT, INC.
CTLT
|
$46.4M |
| 3 |
Charles River Laboratories
CRL
|
$45.6M |
| 4 |
Encompass Health
EHC
|
$44M |
| 5 |
Intuitive Surgical
ISRG
|
$39.8M |
Sector Composition
| 1 | Healthcare | 98.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
HZNP
1
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $62.9M | 9.03% | 574,467 -44,106 | -7% | -$4.83M |
|
|
2
Envista
NVST
$3.52B
| $61.4M | 8.81% | 1,468,787 +568,787 | +63% | +$23.8M |
|
3
Humana
HUM
$36.5B
| $61.3M | 8.8% | 157,643 -23,869 | -13% | -$9.29M |
|
|
NVRO
4
DELISTED
NEVRO CORP.
NVRO
| $47M | 6.74% | 403,424 +120,804 | +43% | +$14.1M |
|
|
5
Hologic
HOLX
$14.9B
| $44.3M | 6.36% | +600,000 | New | +$44.3M |
|
6
AbbVie
ABBV
$372B
| $42.4M | 6.08% | 393,024 -139,499 | -26% | -$15M |
|
|
CTLT
7
DELISTED
CATALENT, INC.
CTLT
| $34.6M | 4.97% | 260,000 -348,429 | -57% | -$46.4M |
|
8
Icon
ICLR
$13.8B
| $34.1M | 4.89% | 130,000 +45,000 | +53% | +$11.8M |
|
9
Molina Healthcare
MOH
$9.8B
| $30.1M | 4.32% | 110,861 -126,352 | -53% | -$34.3M |
|
10
CONMED
CNMD
$1.68B
| $24.9M | 3.57% | 190,000 -27,204 | -13% | -$3.56M |
|
11
Guardant Health
GH
$8.41B
| $23.8M | 3.41% | 190,000 -160,000 | -46% | -$20M |
|
|
12
HCA Healthcare
HCA
$94.5B
| $23.6M | 3.38% | +97,165 | New | +$23.6M |
|
13
Align Technology
ALGN
$10.3B
| $23.3M | 3.34% | 35,000 -30,000 | -46% | -$20M |
|
|
14
Boston Scientific
BSX
$156B
| $21.7M | 3.11% | +500,000 | New | +$21.7M |
|
15
Tenet Healthcare
THC
$16.3B
| $21.1M | 3.03% | 317,797 -166,208 | -34% | -$11M |
|
|
16
Acadia Healthcare
ACHC
$2.12B
| $20.5M | 2.94% | +321,000 | New | +$20.5M |
|
17
Thermo Fisher Scientific
TMO
$186B
| $20M | 2.87% | +35,000 | New | +$20M |
|
18
AstraZeneca
AZN
$248B
| $18M | 2.59% | +300,000 | New | +$18M |
|
|
19
Charles River Laboratories
CRL
$8.04B
| $15.4M | 2.22% | 37,404 -110,524 | -75% | -$45.6M |
|
|
20
Intuitive Surgical
ISRG
$170B
| $14.9M | 2.14% | 15,000 -39,999 | -73% | -$39.8M |
|
21
United Therapeutics
UTHR
$13.8B
| $12.9M | 1.85% | +70,000 | New | +$12.9M |
|
22
Stereotaxis
STXS
$261M
| $10.7M | 1.54% | 1,993,034 +1,800,106 | +933% | +$9.69M |
|
|
OHPAU
23
DELISTED
Orion Acquisition Corp. Unit
OHPAU
| $9.96M | 1.43% | 1,006,229 +144 | +0% | +$1.43K |
|
|
RVNC
24
DELISTED
Revance Therapeutics, Inc.
RVNC
| $9.19M | 1.32% | +330,000 | New | +$9.19M |
|
|
OLK
25
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
| $4.85M | 0.7% | 200,000 +175,000 | +700% | +$4.24M |
|